 Thomas Jansson
Concepts (457)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placenta | 91 | 2025 | 749 | 18.540 |
Why?
| | Trophoblasts | 43 | 2025 | 199 | 10.580 |
Why?
| | Fetal Growth Retardation | 40 | 2025 | 564 | 9.160 |
Why?
| | TOR Serine-Threonine Kinases | 46 | 2025 | 412 | 8.530 |
Why?
| | Fetal Development | 31 | 2025 | 296 | 7.330 |
Why?
| | Maternal-Fetal Exchange | 24 | 2021 | 165 | 5.550 |
Why?
| | Pregnancy | 132 | 2025 | 6729 | 5.380 |
Why?
| | Amino Acids | 23 | 2024 | 497 | 4.780 |
Why?
| | Amino Acid Transport System A | 13 | 2025 | 37 | 4.730 |
Why?
| | Amino Acid Transport Systems | 16 | 2024 | 42 | 4.600 |
Why?
| | Diabetes, Gestational | 17 | 2023 | 316 | 4.320 |
Why?
| | Adiponectin | 14 | 2024 | 244 | 3.970 |
Why?
| | Insulin-Like Growth Factor Binding Protein 1 | 16 | 2023 | 25 | 3.530 |
Why?
| | Pregnancy Complications | 15 | 2024 | 525 | 3.440 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 16 | 2025 | 125 | 3.230 |
Why?
| | Insulin | 30 | 2023 | 2406 | 2.990 |
Why?
| | Insulin-Like Growth Factor I | 16 | 2023 | 316 | 2.810 |
Why?
| | Glucose Intolerance | 5 | 2022 | 146 | 2.720 |
Why?
| | Maternal Nutritional Physiological Phenomena | 12 | 2024 | 176 | 2.650 |
Why?
| | Signal Transduction | 45 | 2025 | 5077 | 2.530 |
Why?
| | Obesity | 23 | 2024 | 2982 | 2.530 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 9 | 2023 | 62 | 2.430 |
Why?
| | Fetal Macrosomia | 11 | 2023 | 62 | 2.310 |
Why?
| | Amino Acid Transport System L | 7 | 2025 | 19 | 2.270 |
Why?
| | Folic Acid | 7 | 2021 | 185 | 2.210 |
Why?
| | Birth Weight | 14 | 2021 | 514 | 2.100 |
Why?
| | Biological Transport | 19 | 2025 | 416 | 2.000 |
Why?
| | Papio | 14 | 2021 | 93 | 1.990 |
Why?
| | Prenatal Exposure Delayed Effects | 10 | 2024 | 605 | 1.940 |
Why?
| | Pregnancy Proteins | 6 | 2022 | 36 | 1.910 |
Why?
| | Female | 137 | 2025 | 72816 | 1.860 |
Why?
| | Fetus | 16 | 2024 | 806 | 1.770 |
Why?
| | Placental Insufficiency | 5 | 2019 | 116 | 1.760 |
Why?
| | Folate Receptor 1 | 4 | 2019 | 15 | 1.620 |
Why?
| | Decidua | 7 | 2022 | 24 | 1.590 |
Why?
| | Cell Membrane | 11 | 2020 | 735 | 1.540 |
Why?
| | Fetal Weight | 7 | 2021 | 56 | 1.530 |
Why?
| | Placentation | 6 | 2021 | 45 | 1.480 |
Why?
| | Insulin Resistance | 10 | 2024 | 1203 | 1.450 |
Why?
| | Multiprotein Complexes | 6 | 2015 | 163 | 1.430 |
Why?
| | Animals | 65 | 2025 | 36850 | 1.380 |
Why?
| | Glucose Transporter Type 1 | 5 | 2020 | 50 | 1.330 |
Why?
| | Down-Regulation | 8 | 2020 | 656 | 1.240 |
Why?
| | Folic Acid Deficiency | 3 | 2021 | 49 | 1.240 |
Why?
| | Extracellular Vesicles | 2 | 2022 | 145 | 1.230 |
Why?
| | Receptors, Adiponectin | 4 | 2024 | 19 | 1.200 |
Why?
| | Fetal Nutrition Disorders | 3 | 2015 | 7 | 1.190 |
Why?
| | Phosphorylation | 23 | 2023 | 1758 | 1.130 |
Why?
| | Pregnancy Trimester, First | 7 | 2021 | 140 | 1.110 |
Why?
| | Heart Diseases | 2 | 2022 | 346 | 1.090 |
Why?
| | Blood Glucose | 7 | 2023 | 2181 | 1.070 |
Why?
| | Fatty Liver | 2 | 2022 | 243 | 1.040 |
Why?
| | Humans | 109 | 2025 | 136803 | 1.020 |
Why?
| | Diet, Protein-Restricted | 2 | 2021 | 11 | 1.000 |
Why?
| | Leucine | 7 | 2021 | 111 | 0.970 |
Why?
| | Transposases | 1 | 2025 | 19 | 0.960 |
Why?
| | Intracellular Signaling Peptides and Proteins | 6 | 2025 | 455 | 0.960 |
Why?
| | Cells, Cultured | 22 | 2021 | 4192 | 0.950 |
Why?
| | Pregnancy Trimesters | 1 | 2025 | 19 | 0.940 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2021 | 858 | 0.930 |
Why?
| | Gestational Age | 14 | 2021 | 902 | 0.920 |
Why?
| | Docosahexaenoic Acids | 6 | 2024 | 84 | 0.890 |
Why?
| | Transcriptome | 4 | 2022 | 969 | 0.860 |
Why?
| | Adiposity | 4 | 2023 | 518 | 0.860 |
Why?
| | Body Mass Index | 13 | 2024 | 2375 | 0.850 |
Why?
| | Lipid Metabolism | 7 | 2024 | 512 | 0.850 |
Why?
| | Reduced Folate Carrier Protein | 3 | 2019 | 10 | 0.840 |
Why?
| | Symporters | 1 | 2023 | 66 | 0.830 |
Why?
| | Pregnancy, Animal | 3 | 2014 | 52 | 0.830 |
Why?
| | Mice | 21 | 2025 | 17759 | 0.820 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 2 | 2021 | 9 | 0.810 |
Why?
| | Infant, Newborn | 21 | 2023 | 6032 | 0.810 |
Why?
| | Caloric Restriction | 2 | 2015 | 123 | 0.790 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2023 | 139 | 0.770 |
Why?
| | Overnutrition | 1 | 2022 | 30 | 0.750 |
Why?
| | Glucose Transport Proteins, Facilitative | 2 | 2014 | 16 | 0.720 |
Why?
| | Glucose | 11 | 2022 | 1019 | 0.710 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 18 | 0.700 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 42 | 0.700 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 3 | 2021 | 283 | 0.690 |
Why?
| | N-Acetylglucosaminyltransferases | 1 | 2020 | 22 | 0.690 |
Why?
| | Pregnancy Trimester, Second | 2 | 2020 | 80 | 0.690 |
Why?
| | Adult | 43 | 2025 | 37643 | 0.690 |
Why?
| | Fatty Acid Transport Proteins | 4 | 2018 | 19 | 0.690 |
Why?
| | Liver | 6 | 2023 | 1940 | 0.680 |
Why?
| | Membrane Transport Proteins | 3 | 2023 | 162 | 0.680 |
Why?
| | Serotonin | 2 | 2020 | 323 | 0.670 |
Why?
| | Overweight | 3 | 2017 | 557 | 0.660 |
Why?
| | Food Deprivation | 3 | 2020 | 25 | 0.660 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2020 | 22 | 0.660 |
Why?
| | Leptin | 4 | 2015 | 236 | 0.650 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2020 | 56 | 0.640 |
Why?
| | DNA Methylation | 3 | 2023 | 640 | 0.630 |
Why?
| | Phospholipids | 4 | 2024 | 222 | 0.620 |
Why?
| | AMP-Activated Protein Kinases | 6 | 2022 | 197 | 0.620 |
Why?
| | Apelin | 1 | 2019 | 10 | 0.620 |
Why?
| | Maternal Exposure | 2 | 2018 | 188 | 0.610 |
Why?
| | Mice, Inbred C57BL | 11 | 2024 | 5750 | 0.610 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 2 | 2015 | 38 | 0.610 |
Why?
| | Protein Kinases | 4 | 2019 | 319 | 0.580 |
Why?
| | PPAR gamma | 5 | 2022 | 182 | 0.580 |
Why?
| | Fatty Acid-Binding Proteins | 4 | 2018 | 70 | 0.580 |
Why?
| | Adaptor Proteins, Signal Transducing | 5 | 2015 | 429 | 0.570 |
Why?
| | Regulatory-Associated Protein of mTOR | 6 | 2019 | 24 | 0.570 |
Why?
| | Case-Control Studies | 7 | 2025 | 3540 | 0.570 |
Why?
| | Fusion Regulatory Protein 1, Light Chains | 2 | 2015 | 6 | 0.560 |
Why?
| | Endocrine Disruptors | 1 | 2018 | 40 | 0.560 |
Why?
| | Phthalic Acids | 1 | 2018 | 40 | 0.560 |
Why?
| | Infant, Premature | 2 | 2022 | 566 | 0.560 |
Why?
| | Fatty Acids, Unsaturated | 4 | 2018 | 98 | 0.550 |
Why?
| | Mice, Obese | 4 | 2022 | 66 | 0.550 |
Why?
| | Metabolic Diseases | 1 | 2018 | 108 | 0.550 |
Why?
| | Casein Kinase II | 7 | 2021 | 21 | 0.550 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2015 | 176 | 0.550 |
Why?
| | Proteome | 2 | 2019 | 472 | 0.540 |
Why?
| | Glucocorticoids | 2 | 2019 | 593 | 0.540 |
Why?
| | Specimen Handling | 1 | 2018 | 181 | 0.540 |
Why?
| | Primary Cell Culture | 7 | 2019 | 171 | 0.540 |
Why?
| | Organ Size | 8 | 2021 | 477 | 0.540 |
Why?
| | RNA Interference | 5 | 2021 | 466 | 0.530 |
Why?
| | Gene Knockdown Techniques | 5 | 2025 | 327 | 0.510 |
Why?
| | Microvilli | 5 | 2019 | 78 | 0.510 |
Why?
| | Homeostasis | 1 | 2020 | 619 | 0.500 |
Why?
| | Disease Models, Animal | 9 | 2022 | 4282 | 0.490 |
Why?
| | Hormones | 2 | 2008 | 142 | 0.490 |
Why?
| | Chorionic Villi | 4 | 2019 | 25 | 0.480 |
Why?
| | Fetal Blood | 4 | 2024 | 327 | 0.480 |
Why?
| | Gene Expression Regulation | 6 | 2021 | 2605 | 0.470 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 5 | 2015 | 59 | 0.470 |
Why?
| | Altitude | 1 | 2019 | 485 | 0.470 |
Why?
| | Diet, High-Fat | 5 | 2024 | 247 | 0.460 |
Why?
| | RNA, Small Interfering | 6 | 2023 | 622 | 0.450 |
Why?
| | Rapamycin-Insensitive Companion of mTOR Protein | 5 | 2019 | 28 | 0.450 |
Why?
| | Homocysteine | 2 | 2017 | 156 | 0.430 |
Why?
| | Weight Gain | 2 | 2015 | 519 | 0.430 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2013 | 29 | 0.420 |
Why?
| | Ubiquitination | 3 | 2022 | 102 | 0.420 |
Why?
| | Vitamin D | 1 | 2016 | 397 | 0.410 |
Why?
| | Nutritional Status | 1 | 2015 | 344 | 0.400 |
Why?
| | Proton-Coupled Folate Transporter | 3 | 2019 | 10 | 0.390 |
Why?
| | Male | 26 | 2023 | 67330 | 0.390 |
Why?
| | Dietary Supplements | 4 | 2024 | 559 | 0.380 |
Why?
| | Placental Circulation | 6 | 2019 | 71 | 0.380 |
Why?
| | Fatty Acids | 5 | 2022 | 442 | 0.380 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 3 | 2016 | 15 | 0.380 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2022 | 437 | 0.370 |
Why?
| | Pregnancy in Diabetics | 3 | 2021 | 122 | 0.370 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 2105 | 0.360 |
Why?
| | PPAR alpha | 4 | 2015 | 58 | 0.340 |
Why?
| | Biological Availability | 2 | 2023 | 148 | 0.330 |
Why?
| | STAT3 Transcription Factor | 2 | 2014 | 206 | 0.330 |
Why?
| | Rats, Wistar | 9 | 2021 | 455 | 0.330 |
Why?
| | Oleic Acid | 3 | 2014 | 40 | 0.330 |
Why?
| | Cohort Studies | 6 | 2023 | 5704 | 0.320 |
Why?
| | Dietary Fats | 2 | 2008 | 304 | 0.320 |
Why?
| | Dietary Proteins | 1 | 2011 | 135 | 0.320 |
Why?
| | Ion Transport | 1 | 2009 | 60 | 0.320 |
Why?
| | Biomarkers | 6 | 2024 | 4145 | 0.310 |
Why?
| | Carrier Proteins | 5 | 2021 | 769 | 0.310 |
Why?
| | Rats | 11 | 2021 | 5639 | 0.310 |
Why?
| | Hypoxia | 3 | 2022 | 1112 | 0.310 |
Why?
| | beta-Alanine | 2 | 2006 | 16 | 0.300 |
Why?
| | In Vitro Techniques | 5 | 2021 | 1089 | 0.290 |
Why?
| | Proteolysis | 2 | 2022 | 177 | 0.290 |
Why?
| | RNA, Messenger | 6 | 2024 | 2831 | 0.280 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 2 | 2023 | 14 | 0.280 |
Why?
| | Exosomes | 2 | 2019 | 103 | 0.280 |
Why?
| | Food | 1 | 2009 | 160 | 0.280 |
Why?
| | Amino Acid Transport Systems, Neutral | 1 | 2007 | 3 | 0.270 |
Why?
| | Endoplasmic Reticulum Stress | 2 | 2020 | 109 | 0.270 |
Why?
| | Malaria, Falciparum | 2 | 2017 | 27 | 0.270 |
Why?
| | Testosterone | 3 | 2016 | 401 | 0.260 |
Why?
| | Choline | 2 | 2024 | 127 | 0.260 |
Why?
| | Young Adult | 10 | 2024 | 13129 | 0.260 |
Why?
| | Taurine | 1 | 2007 | 46 | 0.260 |
Why?
| | Hyperglycemia | 2 | 2007 | 347 | 0.260 |
Why?
| | Protein Transport | 3 | 2021 | 443 | 0.250 |
Why?
| | Up-Regulation | 3 | 2015 | 844 | 0.250 |
Why?
| | Biological Transport, Active | 3 | 2015 | 77 | 0.250 |
Why?
| | Cesarean Section | 2 | 2022 | 183 | 0.250 |
Why?
| | Adult Children | 2 | 2024 | 22 | 0.250 |
Why?
| | CD36 Antigens | 2 | 2016 | 36 | 0.250 |
Why?
| | Hep G2 Cells | 7 | 2021 | 67 | 0.240 |
Why?
| | Hypoglycemic Agents | 3 | 2019 | 1283 | 0.230 |
Why?
| | Energy Intake | 1 | 2008 | 484 | 0.230 |
Why?
| | Chromatography, Liquid | 2 | 2023 | 433 | 0.230 |
Why?
| | Palmitic Acid | 2 | 2014 | 41 | 0.230 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2004 | 51 | 0.230 |
Why?
| | Cell Hypoxia | 3 | 2021 | 226 | 0.230 |
Why?
| | Protein Kinase C-alpha | 2 | 2021 | 37 | 0.230 |
Why?
| | Maternal Age | 3 | 2021 | 129 | 0.220 |
Why?
| | Gene Silencing | 4 | 2021 | 195 | 0.220 |
Why?
| | Amino Acids, Essential | 1 | 2023 | 13 | 0.220 |
Why?
| | Tandem Mass Spectrometry | 2 | 2023 | 532 | 0.210 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2022 | 135 | 0.210 |
Why?
| | Term Birth | 2 | 2015 | 23 | 0.210 |
Why?
| | Umbilical Veins | 2 | 2014 | 61 | 0.200 |
Why?
| | Embryonic Development | 2 | 2021 | 119 | 0.200 |
Why?
| | Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 17 | 0.200 |
Why?
| | 3T3-L1 Cells | 1 | 2022 | 36 | 0.190 |
Why?
| | Body Weight | 3 | 2012 | 985 | 0.190 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2023 | 133 | 0.180 |
Why?
| | Carnitine | 1 | 2022 | 84 | 0.180 |
Why?
| | Fetal Heart | 1 | 2022 | 55 | 0.180 |
Why?
| | Inflammation Mediators | 2 | 2015 | 513 | 0.180 |
Why?
| | Sirolimus | 5 | 2020 | 275 | 0.180 |
Why?
| | Animals, Newborn | 2 | 2018 | 844 | 0.180 |
Why?
| | Glucose Tolerance Test | 1 | 2022 | 364 | 0.180 |
Why?
| | Intra-Abdominal Fat | 1 | 2022 | 91 | 0.180 |
Why?
| | MAP Kinase Signaling System | 3 | 2019 | 320 | 0.180 |
Why?
| | Infant, Low Birth Weight | 2 | 2019 | 140 | 0.170 |
Why?
| | Monoamine Oxidase | 1 | 2020 | 30 | 0.170 |
Why?
| | Cardiomegaly | 1 | 2022 | 175 | 0.170 |
Why?
| | Vitrification | 1 | 2020 | 5 | 0.170 |
Why?
| | Triglycerides | 4 | 2023 | 524 | 0.170 |
Why?
| | Birth Rate | 1 | 2020 | 30 | 0.170 |
Why?
| | Organogenesis | 1 | 2021 | 58 | 0.170 |
Why?
| | Blastocyst | 1 | 2020 | 48 | 0.170 |
Why?
| | Embryo Implantation | 1 | 2020 | 30 | 0.170 |
Why?
| | Embryo Transfer | 1 | 2020 | 32 | 0.170 |
Why?
| | Umbilical Cord | 1 | 2020 | 85 | 0.170 |
Why?
| | Infant | 4 | 2024 | 9395 | 0.170 |
Why?
| | Skinfold Thickness | 1 | 2020 | 46 | 0.170 |
Why?
| | Embryo, Mammalian | 1 | 2021 | 232 | 0.170 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2022 | 366 | 0.170 |
Why?
| | Cell Culture Techniques | 2 | 2021 | 362 | 0.170 |
Why?
| | Adipocytes | 1 | 2022 | 222 | 0.160 |
Why?
| | Mice, Transgenic | 1 | 2025 | 2163 | 0.160 |
Why?
| | Adipose Tissue | 2 | 2019 | 630 | 0.160 |
Why?
| | Child, Preschool | 4 | 2024 | 10997 | 0.160 |
Why?
| | Receptor, Insulin | 1 | 2019 | 105 | 0.160 |
Why?
| | Apelin Receptors | 1 | 2019 | 4 | 0.160 |
Why?
| | Myometrium | 1 | 2019 | 39 | 0.160 |
Why?
| | Pediatric Obesity | 2 | 2024 | 590 | 0.160 |
Why?
| | Organelle Biogenesis | 1 | 2019 | 15 | 0.150 |
Why?
| | Enzyme Activation | 3 | 2015 | 810 | 0.150 |
Why?
| | Lysophosphatidylcholines | 1 | 2018 | 22 | 0.150 |
Why?
| | Immunohistochemistry | 3 | 2018 | 1733 | 0.150 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2019 | 54 | 0.150 |
Why?
| | Protein Kinase C | 2 | 2021 | 261 | 0.150 |
Why?
| | Myoblasts, Skeletal | 1 | 2018 | 12 | 0.150 |
Why?
| | Olive Oil | 1 | 2018 | 3 | 0.150 |
Why?
| | Metabolomics | 1 | 2024 | 678 | 0.150 |
Why?
| | Electron Transport | 1 | 2019 | 115 | 0.150 |
Why?
| | Protein Interaction Maps | 1 | 2018 | 48 | 0.150 |
Why?
| | PPAR delta | 1 | 2018 | 5 | 0.150 |
Why?
| | Tetrahydrofolates | 1 | 2018 | 18 | 0.150 |
Why?
| | Models, Biological | 4 | 2021 | 1773 | 0.140 |
Why?
| | Receptors, Glucocorticoid | 1 | 2019 | 155 | 0.140 |
Why?
| | Oxidative Phosphorylation | 1 | 2019 | 193 | 0.140 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2017 | 30 | 0.140 |
Why?
| | Piperidines | 1 | 2019 | 206 | 0.140 |
Why?
| | alpha-Linolenic Acid | 1 | 2017 | 8 | 0.140 |
Why?
| | Lipids | 1 | 2022 | 665 | 0.140 |
Why?
| | Child | 6 | 2024 | 21819 | 0.140 |
Why?
| | Glyburide | 1 | 2017 | 32 | 0.140 |
Why?
| | Time Factors | 2 | 2025 | 6809 | 0.140 |
Why?
| | Mice, Inbred ICR | 1 | 2017 | 119 | 0.140 |
Why?
| | Blood Platelets | 1 | 2020 | 407 | 0.130 |
Why?
| | Arachidonic Acid | 1 | 2017 | 120 | 0.130 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2017 | 9 | 0.130 |
Why?
| | Rats, Sprague-Dawley | 3 | 2007 | 2486 | 0.130 |
Why?
| | Protein Processing, Post-Translational | 3 | 2015 | 465 | 0.130 |
Why?
| | Phosphoproteins | 2 | 2011 | 337 | 0.130 |
Why?
| | Receptors, Calcitriol | 1 | 2016 | 55 | 0.130 |
Why?
| | Electroacupuncture | 1 | 2016 | 2 | 0.130 |
Why?
| | Muscle Contraction | 1 | 2019 | 423 | 0.130 |
Why?
| | Cholecalciferol | 1 | 2016 | 60 | 0.130 |
Why?
| | Prenatal Diagnosis | 1 | 2018 | 200 | 0.130 |
Why?
| | Coenzyme A Ligases | 1 | 2016 | 13 | 0.130 |
Why?
| | Obstetrics | 1 | 2018 | 162 | 0.130 |
Why?
| | Amino Acid Transport System y+L | 1 | 2015 | 4 | 0.120 |
Why?
| | Echocardiography | 1 | 2019 | 643 | 0.120 |
Why?
| | Resource Allocation | 1 | 2016 | 52 | 0.120 |
Why?
| | Prospective Studies | 2 | 2021 | 7573 | 0.120 |
Why?
| | Caspase 3 | 2 | 2014 | 246 | 0.120 |
Why?
| | Fatty Acid Binding Protein 3 | 1 | 2015 | 6 | 0.120 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 2015 | 14 | 0.120 |
Why?
| | Androgens | 1 | 2017 | 187 | 0.120 |
Why?
| | Excitatory Amino Acids | 1 | 2015 | 7 | 0.120 |
Why?
| | Gynecology | 1 | 2018 | 168 | 0.120 |
Why?
| | Transport Vesicles | 1 | 2015 | 18 | 0.120 |
Why?
| | Dietary Sucrose | 1 | 2015 | 49 | 0.120 |
Why?
| | Proteomics | 1 | 2022 | 1109 | 0.120 |
Why?
| | Diet | 3 | 2022 | 1274 | 0.120 |
Why?
| | Hepatocytes | 2 | 2014 | 220 | 0.120 |
Why?
| | Lipase | 1 | 2015 | 69 | 0.120 |
Why?
| | Heart | 1 | 2019 | 653 | 0.120 |
Why?
| | Anti-Inflammatory Agents | 1 | 2019 | 496 | 0.120 |
Why?
| | Autophagy | 1 | 2017 | 280 | 0.120 |
Why?
| | Interleukin-1beta | 2 | 2014 | 371 | 0.110 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2015 | 155 | 0.110 |
Why?
| | Amygdala | 1 | 2015 | 191 | 0.110 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2017 | 361 | 0.110 |
Why?
| | Analysis of Variance | 2 | 2017 | 1316 | 0.110 |
Why?
| | Myocardium | 1 | 2019 | 1001 | 0.110 |
Why?
| | bcl-2-Associated X Protein | 1 | 2013 | 56 | 0.110 |
Why?
| | Prognosis | 2 | 2019 | 4013 | 0.100 |
Why?
| | Environmental Exposure | 1 | 2018 | 572 | 0.100 |
Why?
| | Transfection | 1 | 2015 | 941 | 0.100 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2021 | 2518 | 0.100 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2013 | 32 | 0.100 |
Why?
| | Receptor, IGF Type 1 | 3 | 2021 | 65 | 0.100 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2017 | 390 | 0.100 |
Why?
| | Ovarian Neoplasms | 1 | 2019 | 562 | 0.100 |
Why?
| | Ceramides | 1 | 2014 | 118 | 0.100 |
Why?
| | Epigenesis, Genetic | 1 | 2018 | 657 | 0.100 |
Why?
| | Blood Urea Nitrogen | 1 | 2012 | 54 | 0.100 |
Why?
| | Protein Subunits | 1 | 2013 | 239 | 0.100 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2829 | 0.100 |
Why?
| | Apoptosis | 2 | 2019 | 2552 | 0.100 |
Why?
| | Hyperandrogenism | 1 | 2012 | 21 | 0.100 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1710 | 0.100 |
Why?
| | Behavior, Animal | 1 | 2015 | 497 | 0.100 |
Why?
| | Mitochondria | 1 | 2019 | 946 | 0.100 |
Why?
| | Energy Metabolism | 2 | 2015 | 919 | 0.100 |
Why?
| | Oxygen | 1 | 2017 | 930 | 0.100 |
Why?
| | MicroRNAs | 1 | 2018 | 692 | 0.090 |
Why?
| | Brain | 1 | 2023 | 2664 | 0.090 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2011 | 21 | 0.090 |
Why?
| | Liver Neoplasms | 1 | 2017 | 785 | 0.090 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2012 | 159 | 0.090 |
Why?
| | Phosphatidylcholines | 2 | 2023 | 147 | 0.080 |
Why?
| | Biomedical Research | 1 | 2017 | 688 | 0.080 |
Why?
| | Colorado | 1 | 2020 | 4515 | 0.080 |
Why?
| | Mass Screening | 1 | 2018 | 1267 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2018 | 1322 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1301 | 0.080 |
Why?
| | Stromal Cells | 2 | 2021 | 112 | 0.080 |
Why?
| | Mothers | 1 | 2015 | 752 | 0.080 |
Why?
| | Cross-Sectional Studies | 4 | 2022 | 5424 | 0.070 |
Why?
| | Microscopy, Fluorescence | 2 | 2021 | 397 | 0.070 |
Why?
| | Anxiety | 1 | 2015 | 1031 | 0.070 |
Why?
| | Immunity, Innate | 1 | 2014 | 825 | 0.070 |
Why?
| | Inflammation | 2 | 2022 | 2835 | 0.070 |
Why?
| | Pregnancy Trimester, Third | 1 | 2008 | 114 | 0.070 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenases | 1 | 2007 | 3 | 0.070 |
Why?
| | Sex Factors | 1 | 2013 | 2064 | 0.070 |
Why?
| | Glucose Transporter Type 3 | 1 | 2007 | 13 | 0.070 |
Why?
| | Amino Acid Transport System y+ | 1 | 2007 | 9 | 0.070 |
Why?
| | Hyperlipoproteinemia Type I | 1 | 2007 | 6 | 0.070 |
Why?
| | Fluorescent Antibody Technique | 2 | 2018 | 388 | 0.070 |
Why?
| | Uterus | 2 | 2019 | 215 | 0.070 |
Why?
| | Sex Characteristics | 2 | 2023 | 763 | 0.070 |
Why?
| | Lipoprotein Lipase | 1 | 2007 | 59 | 0.070 |
Why?
| | Oxidative Stress | 2 | 2018 | 1314 | 0.070 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2006 | 22 | 0.060 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2018 | 195 | 0.060 |
Why?
| | Glucose Clamp Technique | 1 | 2007 | 195 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3265 | 0.060 |
Why?
| | Mass Spectrometry | 2 | 2021 | 738 | 0.060 |
Why?
| | Lentivirus | 1 | 2025 | 56 | 0.060 |
Why?
| | Interviews as Topic | 1 | 2008 | 772 | 0.060 |
Why?
| | Lactic Acid | 1 | 2006 | 305 | 0.060 |
Why?
| | Osmolar Concentration | 1 | 2004 | 171 | 0.060 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2004 | 200 | 0.060 |
Why?
| | Ephrin-A3 | 1 | 2024 | 1 | 0.060 |
Why?
| | Ephrins | 1 | 2024 | 8 | 0.050 |
Why?
| | Microscopy, Electron | 1 | 2004 | 432 | 0.050 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2017 | 176 | 0.050 |
Why?
| | Ether | 1 | 2023 | 8 | 0.050 |
Why?
| | Ethyl Ethers | 1 | 2023 | 4 | 0.050 |
Why?
| | Plasmalogens | 1 | 2023 | 6 | 0.050 |
Why?
| | Ethers | 1 | 2023 | 19 | 0.050 |
Why?
| | Connexins | 1 | 2024 | 48 | 0.050 |
Why?
| | Lipocalin-2 | 1 | 2024 | 79 | 0.050 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 2 | 2014 | 162 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2023 | 77 | 0.050 |
Why?
| | Electrolytes | 1 | 2003 | 58 | 0.050 |
Why?
| | Cell Cycle Proteins | 1 | 2007 | 613 | 0.050 |
Why?
| | Receptors, Androgen | 2 | 2015 | 150 | 0.050 |
Why?
| | Body Composition | 1 | 2007 | 679 | 0.050 |
Why?
| | Pregnancy, High-Risk | 1 | 2002 | 14 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 2052 | 0.050 |
Why?
| | Insulin, Regular, Human | 1 | 2022 | 43 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2006 | 778 | 0.050 |
Why?
| | Insulin Receptor Substrate Proteins | 2 | 2013 | 59 | 0.050 |
Why?
| | Maleimides | 1 | 2021 | 23 | 0.050 |
Why?
| | Cell Shape | 1 | 2021 | 57 | 0.050 |
Why?
| | Receptors, Erythropoietin | 1 | 2021 | 20 | 0.050 |
Why?
| | Norway | 1 | 2021 | 43 | 0.050 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2021 | 150 | 0.050 |
Why?
| | Esterification | 1 | 2020 | 9 | 0.040 |
Why?
| | Cholesterol | 1 | 2023 | 410 | 0.040 |
Why?
| | Metabolome | 1 | 2024 | 350 | 0.040 |
Why?
| | Parity | 1 | 2021 | 125 | 0.040 |
Why?
| | Epithelial Cells | 1 | 2007 | 1094 | 0.040 |
Why?
| | Reference Values | 1 | 2002 | 816 | 0.040 |
Why?
| | Erythropoietin | 1 | 2021 | 95 | 0.040 |
Why?
| | Receptors, Amino Acid | 1 | 2020 | 25 | 0.040 |
Why?
| | NF-kappa B | 2 | 2014 | 691 | 0.040 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 278 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 851 | 0.040 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2019 | 27 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2020 | 165 | 0.040 |
Why?
| | Cell Cycle Checkpoints | 1 | 2019 | 98 | 0.040 |
Why?
| | Sodium | 1 | 2020 | 216 | 0.040 |
Why?
| | Erythrocytes | 1 | 2024 | 699 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 171 | 0.040 |
Why?
| | Arachidonic Acids | 1 | 2018 | 62 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2021 | 543 | 0.040 |
Why?
| | Hippocampus | 1 | 2024 | 894 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2024 | 778 | 0.040 |
Why?
| | Neoplasm Grading | 1 | 2019 | 305 | 0.040 |
Why?
| | Perilipin-2 | 1 | 2018 | 41 | 0.040 |
Why?
| | Mitosis | 1 | 2019 | 192 | 0.040 |
Why?
| | Indoles | 1 | 2021 | 410 | 0.040 |
Why?
| | Adolescent | 3 | 2019 | 21385 | 0.040 |
Why?
| | Environmental Health | 1 | 2018 | 48 | 0.040 |
Why?
| | Phagosomes | 1 | 2017 | 44 | 0.030 |
Why?
| | Lipogenesis | 1 | 2017 | 61 | 0.030 |
Why?
| | Lysosomes | 1 | 2017 | 141 | 0.030 |
Why?
| | Sheep | 1 | 2020 | 856 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1059 | 0.030 |
Why?
| | Phosphoserine | 1 | 2015 | 34 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1507 | 0.030 |
Why?
| | Blotting, Western | 2 | 2010 | 1225 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 2015 | 153 | 0.030 |
Why?
| | Corticosterone | 1 | 2016 | 236 | 0.030 |
Why?
| | Adenylate Kinase | 1 | 2014 | 26 | 0.030 |
Why?
| | Caspase 10 | 1 | 2014 | 5 | 0.030 |
Why?
| | Chorionic Gonadotropin | 1 | 2014 | 80 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 968 | 0.030 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2014 | 114 | 0.030 |
Why?
| | GRB2 Adaptor Protein | 1 | 2013 | 13 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2014 | 92 | 0.030 |
Why?
| | Transcription Factors | 1 | 2021 | 1718 | 0.030 |
Why?
| | Transgenes | 1 | 2014 | 179 | 0.030 |
Why?
| | Estradiol Dehydrogenases | 1 | 2012 | 1 | 0.030 |
Why?
| | Incidence | 1 | 2019 | 2797 | 0.020 |
Why?
| | Estrous Cycle | 1 | 2012 | 20 | 0.020 |
Why?
| | Binding Sites | 1 | 2015 | 1301 | 0.020 |
Why?
| | Metabolic Networks and Pathways | 1 | 2013 | 180 | 0.020 |
Why?
| | Random Allocation | 1 | 2012 | 353 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2138 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2019 | 2476 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3406 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2894 | 0.020 |
Why?
| | Dexamethasone | 1 | 2013 | 368 | 0.020 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 273 | 0.020 |
Why?
| | Attitude of Health Personnel | 1 | 2018 | 1163 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2012 | 436 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1116 | 0.020 |
Why?
| | Blood Pressure | 1 | 2016 | 1774 | 0.020 |
Why?
| | Gene Expression | 1 | 2013 | 1500 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 33239 | 0.020 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2007 | 30 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1059 | 0.020 |
Why?
| | Carbon Radioisotopes | 1 | 2006 | 34 | 0.020 |
Why?
| | Permeability | 1 | 2006 | 161 | 0.020 |
Why?
| | Cytokines | 1 | 2014 | 2084 | 0.020 |
Why?
| | Protons | 1 | 2006 | 89 | 0.020 |
Why?
| | Amniotic Fluid | 1 | 2006 | 96 | 0.020 |
Why?
| | Muscle Proteins | 1 | 2006 | 228 | 0.010 |
Why?
| | Ultrasonography, Prenatal | 1 | 2006 | 284 | 0.010 |
Why?
| | Aged | 1 | 2024 | 23808 | 0.010 |
Why?
| | Phenotype | 1 | 2005 | 3189 | 0.010 |
Why?
|
|
Jansson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|